Fundz

French biotech SeaBeLife raises €2M in pre-Series A funding led by iXLife to advance its drug development pipeline for liver and eye diseases.

PRIVATEOct 01, 2025

Amount Raised

€2 Million

Round Type

Pre-Series A

BiotechnologyHealth Careresearch

Investors

WeLikeStartupiXLifeBreizh AngelsFemmes Business AngelsInextAngels SantéBusiness Angels Des Grandes Ecoles

Description

SeaBeLife has secured €2 million in a pre-Series A funding round to advance its drug development pipeline, with clinical trials expected to begin in 2026. This financing will support two core therapeutic programmes targeting severe acute hepatitis and dry age-related macular degeneration. The funding round was led by existing investor iXLife, with contributions from new backers like INEXT and Femmes Business Angels. The renewed backing signals confidence in SeaBeLife's vision and development strategy.

Quick answer

SeaBeLife raised €2 Million in a Pre-Series A round, dated October 1, 2025. Investors: WeLikeStartup, iXLife, Breizh Angels, Femmes Business Angels, Inext, Angels Santé and Business Angels Des Grandes Ecoles.

How much did SeaBeLife raise?
SeaBeLife raised €2 Million in a Pre-Series A round on October 1, 2025.
Who invested in SeaBeLife?
WeLikeStartup, iXLife, Breizh Angels, Femmes Business Angels, Inext, Angels Santé and Business Angels Des Grandes Ecoles are named as investors in this round.
What does SeaBeLife do?
SeaBeLife is developing first-in-class small molecules designed to inhibit both necroptosis and ferroptosis, two regulated cell death pathways implicated in tissue damage associated with rare, acute and chronic diseases.
Where is SeaBeLife based and how big is it?
Fundz records about 10 employees.
Who are the decision-makers at SeaBeLife?
Fundz holds 1 contact at SeaBeLife. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as SeaBeLife that raised within 45 days of this round, from Fundz verified event records.

  • Brainstorm Cell Therapeutics raised $155K (Convertible Note) on November 6, 2025.
  • Hepta raised $6.7M (Seed) on November 5, 2025.
  • AAVantgarde Bio raised $141M (Series B) on November 3, 2025.
  • Cyclana Bio raised $6.7M (Pre-Seed) on October 20, 2025.
  • Grail raised $325M (Post-IPO Equity) on October 20, 2025.
  • Faeth Therapeutics raised $25M (Funding Round) on October 20, 2025.

Who to call at SeaBeLife, and when

A new round usually means SeaBeLife is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day SeaBeLife raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SeaBeLife, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SeaBeLife. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SeaBeLife

Location

Place Georges Teissier

About

SeaBeLife is developing first-in-class small molecules designed to inhibit both necroptosis and ferroptosis, two regulated cell death pathways implicated in tissue damage associated with rare, acute and chronic diseases. This dual-target approach is currently not available on the market and is seen as a potentially transformative strategy in organ protection.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SeaBeLife raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for SeaBeLife's next move

See what Strategic adds

SeaBeLife raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.